Growth of kidney-transplanted pediatric patients treated with sirolimus

Pediatric Nephrology

Volumn 26, Issue 6, 2011, Pages 961-966

  González, David ^a   García, Clotilde D ^b   Azócar, Marta ^c   Waller, Simon ^d   Alonso, Angel ^e   Ariceta, Gema ^f   Mejía, Natalia ^g   Santos, Fernando ^a,h  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Santo Antonio Children's Hospital   (Brazil)

^c HOSPITAL LUIS CALVO MACKENNA   (Chile)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL DE CRUCES   (Spain)

^g Hospital Universitario de la Fundacion   (Colombia)

^h UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Child; Growth failure; Kidney transplant; Rapamycin; Renal failure; Sirolimus

Indexed keywords

CORTICOSTEROID; RAPAMYCIN;

ARTICLE; BODY GROWTH; BODY HEIGHT; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROWTH RATE; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; SCHOOL CHILD;

CHILD; FEMALE; GRAFT REJECTION; GROWTH DISORDERS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SIROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79959963307     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1811-3     Document Type: Article

References (29)

1. Sehgal SN (2003) Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 35:7S-14S (Pubitemid 36547910)
2. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18:1926-1945 (Pubitemid 39071573)
3. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128-135 (Pubitemid 34155123)
4. Ibáñez JP, Monteverde ML, Diaz MA, Goldberg J, Turconi AF (2007) Sirolimus in chronic allograft nephropathy in pediatric recipients. Pediatr Transplant 11:777-780 (Pubitemid 47512321)
5. Höcker B, Feneberg R, Köpf S, Weber LT, Waldherr R, Wühl E, Tönshoff B (2006) SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity. Pediatr Transplant 10:593-601
6. Ibáñez JP, Monteverde ML, Goldberg J, Diaz MA, Turconi A (2005) Sirolimus in pediatric renal transplantation. Transplant Proc 37:682-684 (Pubitemid 40590669)
7. Mota A, Arias M, Taskinen EI, Paavonen T, Brault Y, Legendre C, Claesson K, Castagneto M, Campistol JM, Hutchison B, Burke JT, Yilmaz S, Häyry P, Neylan JF (2004) Sirolimus-based therapy following early Cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 4:953-961 (Pubitemid 38745595)
8. Falger JC, Mueller T, Arbeiter K, Boehm M, Regele H, Balzar E, Aufricht C (2006) Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy. Pediatr Transplant 10:565-569
9. Mathew T, Kreis H, Friend P (2004) Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 18:446-449 (Pubitemid 39077081)
10. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G (2005) Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352:1317-1323 (Pubitemid 40411498)
11. Sindhi R (2003) Sirolimus in pediatric transplant recipients. Transplant Proc 35:113S-114S (Pubitemid 36547927)
12. Alvarez-García O, García-López E, Loredo V, Gil-Peña H, Rodríguez-Suárez J, Ordóñez FA, Carbajo-Pérez E, Santos F (2010) Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate. Kidney Int 78:561-568
13. Alvarez-Garcia O, Carbajo-Pérez E, Garcia E, Gil H, Molinos I, Rodriguez J, Ordoñez FA, Santos F (2007) Rapamycin retards growth and causes marked alterations in the growth plate of young rats. Pediatr Nephrol 22:954-961 (Pubitemid 46881913)
14. Sanchez CP, He YZ (2009) Bone growth during rapamycin therapy in young rats. BMC Pediatr 9:3
15. Rangel GA, Ariceta G (2009) Growth failure associated with sirolimus: case report. Pediatr Nephrol 24:2047-2050
16. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Amst 34:571-590 (Pubitemid 17080631)
17. Tanner JM, Marshall WA, Healy MJ, Goldstein H (1983) Assessment of skeletal maturity and prediction of adult height (tw2 method). 2nd edn. Academic Press, New York
18. Fine RN (2010) Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Pediatr Nephrol 25:725-732
19. Nissel R, Brázda I, Feneberg R, Wigger M, Greiner C, Querfeld U, Haffner D (2004) Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int 66:792-800 (Pubitemid 38982024)
20. Grenda R, Watson A, Trompeter R, Tönshoff B, Jaray J, Fitzpatrick M, Murer L, Vondrak K, Maxwell H, van Damme-Lombaerts R, Loirat C, Mor E, Cochat P, Milford DV, Brown M, Webb NJ (2010) A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. Am J Transplant 10:828-836
21. Ferraris JR, Pasqualini T, Alonso G, Legal S, Sorroche P, Galich A, Coccia P, Ghezzi L, Ferraris V, Karabatas L, Guida C, Jasper H (2010) A study on strategies for improving growth and body composition after renal transplantation. Pediatr Nephrol 25:753-762
22. Li L, Chang A, Naesens M, Kambham N, Waskerwitz J, Martin J, Wong C, Alexander S, Grimm P, Concepcion W, Salvatierra O, Sarwal MM (2009) Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patients benefits. Am J Transplant 9:1362-1372
23. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr (2003) Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 76:1331-1339 (Pubitemid 37430720)
24. Grenda R (2010) Effects of steroid avoidance and novel protocols on growth in paediatric renal transplant patients. Pediatr Nephrol 25:747-752
25. Tejani A, Fine R, Alexander S, Harmon W, Stablein D (1993) Factors predictive of sustained growth in children after renal transplantation. J Pediatr 122:397-402 (Pubitemid 23067219)
26. Harambat J, Cochat P (2009) Growth after renal transplantation. Pediatr Nephrol 24:1297-1306
27. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) 2008 annual report. Available at: https://web.emmes.com/study/ped/annlrept/ annlrept.html. Accessed 8 Oct 2009.
28. Alvarez-Garcia O, Garcia-Lopez E, Loredo V, Gil-Peña H, Rodriguez J, Ordoñez FA, Santos F (2010) Growth hormone (GH) administration improves longitudinal growth in rats withgrowth retardation induced by rapamycin. Pediatr Nephrol 25:31A
29. Warshaw BL, Hymes LC (2010) Linear growth in pediatric renal transplant recipients is similar with sirolimus vs. calcineurin inhibitors. Presented at the American Transplant Congress, San Diego (CA) 2010 (abstract).